Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950138-07-000670
Filing Date
2007-08-27
Accepted
2007-08-27 16:52:35
Documents
1
Period of Report
2007-08-17

Document Format Files

Seq Description Document Type Size
1 ROTH-STARK FILINGS\2007\AUG 27 ISOLAGEN-3 aug27_isolagen-3ex.html 3  
1 ROTH-STARK FILINGS\2007\AUG 27 ISOLAGEN-3 aug27_isolagen-3ex.xml 3 4037
  Complete submission text file 0000950138-07-000670.txt   6645
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Issuer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 4142411810
ROTH MICHAEL (Reporting) CIK: 0001010207 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 071081254

Mailing Address 10556 N PORT WASHINGTON RD MEQUON WI 53092
Business Address 3600 SOUTH LAKE DR ST FRANCIS WI 53235 414 294 7000
STARK BRIAN JAY (Reporting) CIK: 0001010208 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31564 | Film No.: 071081253